January 6, 2025 - 13:09

After my husband's cancer diagnosis, my life took an unexpected turn as I became his primary caregiver. The emotional toll was immense, and I quickly realized that my routines were completely upended. The demands of caregiving often overshadowed my own needs, making self-care feel like an impossible task.
In the early days, I struggled to find balance, often neglecting my physical and emotional well-being. It became clear that I couldn't navigate this journey alone. I decided to reach out to family members and other caregivers for support. Their understanding and shared experiences provided a sense of relief and comfort during this challenging time.
Through open conversations and shared moments, I learned the importance of prioritizing my own health alongside my husband's care. I discovered that seeking help is not a sign of weakness but rather a crucial step in maintaining resilience. This experience has taught me that self-care is essential, especially in the face of adversity.
January 25, 2026 - 20:36
Minnesota’s Biggest Companies Call for ‘De-escalation’ of TensionsChief executives from several of Minnesota`s largest and most prominent companies, including retail giant Target and agricultural conglomerate Cargill, have jointly issued a public letter calling...
January 25, 2026 - 12:28
Bob on Business: Fort Worth Stock Show with a high-end ‘Landman’ twistThe iconic Fort Worth Stock Show & Rodeo, a century-old celebration of Western heritage, is witnessing a notable shift in its patronage, reflecting the region`s booming energy sector. Observers...
January 24, 2026 - 23:38
How seat-back psychology helped a WA business build a safety card dynastyNestled in Lacey, Washington, a quiet manufacturing success story has been unfolding for decades, one airplane seat-back pocket at a time. A local company has become an unlikely dynasty, producing...
January 24, 2026 - 02:33
Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trialsThe pharmaceutical company Moderna is scaling back its plans to invest in new late-stage clinical trials for infectious disease vaccines, citing a challenging environment. A significant factor in...